gefitinib has been researched along with Radiation Pneumonitis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aono, Y; Hanibuchi, M; Kakiuchi, S; Kishi, J; Miyake, K; Nishioka, Y; Sone, S; Suzuka, C; Tani, K; Tezuka, T; Toyoda, Y; Yuasa, S | 1 |
Goya, T; Koshiishi, Y; Miya, T; Ono, Y; Tanaka, H | 1 |
Shiratori, M; Takahashi, H | 1 |
1 review(s) available for gefitinib and Radiation Pneumonitis
Article | Year |
---|---|
[Diffuse lung diseases and biological markers in serum].
Topics: Antibodies, Monoclonal; Antigens, Neoplasm; Biomarkers; Collagen Diseases; Gefitinib; Humans; Lung Diseases, Interstitial; Mucin-1; Mucins; Pulmonary Surfactant-Associated Protein A; Pulmonary Surfactant-Associated Protein D; Quinazolines; Radiation Pneumonitis; Reagent Kits, Diagnostic; Respiratory Distress Syndrome; Sensitivity and Specificity | 2006 |
2 other study(ies) available for gefitinib and Radiation Pneumonitis
Article | Year |
---|---|
Epidermal growth factor receptor-tyrosine kinase inhibitor (gefitinib) augments pneumonitis, but attenuates lung fibrosis in response to radiation injury in rats.
Topics: Animals; Disease Models, Animal; ErbB Receptors; Gefitinib; Male; Protein Kinase Inhibitors; Pulmonary Fibrosis; Quinazolines; Radiation Pneumonitis; Rats; Rats, Wistar | 2012 |
[Radiation recall pneumonitis induced by Gefitinib (Iressa): a case report].
Topics: Aged; Antineoplastic Agents; Carcinoma, Large Cell; Combined Modality Therapy; Enzyme Inhibitors; Gefitinib; Humans; Lung Neoplasms; Male; Protein-Tyrosine Kinases; Quinazolines; Radiation Pneumonitis | 2003 |